World Health Organization's List of Essential Medicines
GPTKB entity
Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical guideline
|
| gptkbp:abbreviation |
gptkb:WHO_Model_List_of_Essential_Medicines
|
| gptkbp:category |
gptkb:public_policy
pharmaceuticals public health |
| gptkbp:contains |
essential medicines
|
| gptkbp:criteria |
safety
cost-effectiveness efficacy public health relevance |
| gptkbp:firstPublished |
1977
|
| gptkbp:hasPediatricVersion |
gptkb:WHO_Model_List_of_Essential_Medicines_for_Children
|
| https://www.w3.org/2000/01/rdf-schema#label |
World Health Organization's List of Essential Medicines
|
| gptkbp:includes |
complementary medicines
core medicines |
| gptkbp:influenced |
national essential medicines lists
|
| gptkbp:language |
English
|
| gptkbp:latestReleaseVersion |
2023
23rd edition |
| gptkbp:maintainedBy |
gptkb:World_Health_Organization
|
| gptkbp:numberOfMedicines |
over 300
|
| gptkbp:purpose |
identify most effective and safe medicines for health systems
|
| gptkbp:relatedTo |
gptkb:World_Health_Organization
Access to medicines Essential medicines Universal health coverage |
| gptkbp:updated |
every two years
|
| gptkbp:usedBy |
countries worldwide
|
| gptkbp:usedFor |
health system strengthening
guiding procurement and supply of medicines improving access to medicines |
| gptkbp:website |
https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines
|
| gptkbp:bfsParent |
gptkb:dexamethasone
|
| gptkbp:bfsLayer |
5
|